Podcast

Low-Value Services: Their Impact and Challenges With Addressing Them

Jason Buxbaum, MHSA, project manager, V-BID Health; and Robert Dubois, MD, PhD, chief scientific officer, National Pharmaceutical Council, discuss low-value services, their financial impact, what states are doing to address them, and challenges with addressing them.

As conversations surrounding rising healthcare costs persist, the idea of addressing low-value services has caught the attention of health professionals nationwide. Value-Based Insurance Design (V-BID) Health’s Task Force on Low-Value Care has identified a top 5 list of low-value clinical services that can be targeted.

We spoke with Jason Buxbaum, MHSA, project manager, V-BID Health, about which 5 low-value services topped the list, the financial impact they have, and how states are attempting to address them.

Once low-value services are identified, healthcare professionals face another challenge: turning conversation into something actionable. We discussed the challenges with addressing these low-value services with Buxbaum and Robert Dubois, MD, PhD, chief scientific officer, National Pharmaceutical Council.

Listen above or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Related Videos
Julie Patterson, PharmD, PhD
Dr Julie Patterson, National Pharmaceutical Council
Kimberly Westrich, MA
Julie Patterson, PharmD, PhD, National Pharmaceutical Council
Eneline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA
Sharon Phares, PhD, MPH
Sharon Phares, PhD, MPH
Sharon Phares, PhD, MPH
Sharon Phares, PhD, MPH
Kimberly Westrich, MA, vice president of Health Services Research at the National Pharmaceutical Council.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo